Evaluating the Origin of the Brain Metastatic Tumors by Using DWI Parameters
International Clinical Neuroscience Journal,
Vol. 6 No. 3 (2019),
31 August 2019
Background: Brain metastases are the most common tumors in the human central nervous system (CNS), with an occurrence 10 times higher than primary brain tumors in adults. A radiologist usually diagnoses these tumors. Typically, magnetic resonance imaging (MRI) has been used to evaluate the status and number of metastases, the design of surgical treatment or radiotherapy, and the response to treatment. This study aimed to consider the origin of metastatic tumors of the brain using diffusion-weighted imaging sequence.
Methods: In this study, 95 lesions observed in 51 patients with different types of brain metastasis who analyzed with standard brain MRI protocols such as T2-weighted fast spin-echo in sagittal, coronal and axial planes and T1-weighted spin-echo sequences before and after injection of contrast enhancement and diffusion-weighted imaging. The diffusion-weighted imaging included an echo-planar spin-echo sequence with two b values (0,1000 s/mm) and calculated apparent diffusion coefficient (ADC) maps. We measured the ADC-value on normalized ADC maps and compared them with different methods. ANOVA was used to compare ADC among all groups as well as T-test for every two groups.
Results: The results showed that patients with lung cancer (squamous cell carcinoma, SCC) had the lowest mean ADC (658.70*10-3 mm2/s) and breast cancer patients with the highest mean ADC(935.52*10-3 mm2/s). This study demonstrated that most Brain metastases had low and intermediate ADC values. The analysis showed no significant difference among all groups. However, ADC values in breast cancer and kidney and lung (adenocarcinoma) were statistically higher in comparison to other groups. There were no critical discrepancies between ADC values in brain metastases from Breast cancer and lung cancer (adenocarcinoma) and kidney.
Conclusion: It seems that evaluating the origin of the brain metastatic tumors by using diffusion imaging (DWI) parameters could be helpful to prevent invasive methods like biopsies in some situations. Although it needs more studies to achieve this purpose.
- Metastatic tumors
- Magnetic resonance imaging
How to Cite
Zakaria R, Das K, Bhojak M, Radon M, Walker C, Jenkinson MD. The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. Cancer Imaging. 2014;14:8. doi: 10.1186/1470-7330-14-8.
Nowosielski M, Radbruch A. The emerging role of advanced neuroimaging techniques for brain metastases. Chin Clin Oncol. 2015;4(2):23. doi: 10.3978/j.issn.2304- 3865.2015.05.04.
Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R, Korogi Y, et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol. 2006;27(7):1419-25.
Zakaria R, Das K, Radon M, Bhojak M, Rudland PR, Sluming V, et al. Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes. BMC Med Imaging. 2014;14:26. doi: 10.1186/1471-2342-14-26.
Berghoff AS, Spanberger T, Ilhan-Mutlu A, Magerle M, Hutterer M, Woehrer A, et al. Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times. PLoS One. 2013;8(2):e55464. doi: 10.1371/ journal.pone.0055464.
Nieder C, Grosu AL, Gaspar LE. Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol. 2014;9:155. doi: 10.1186/1748-717x-9-155.
Ahluwalia M, Vogelbaum M, Chao S, Mehta M. Brain metastasis and treatment. F1000Prime Rep; 2014;6.
Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A. 1999;96(14):7714-8. doi: 10.1073/ pnas.96.14.7714.
Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol. 2001;22(5):969-76.
Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol. 2001;22(6):1081- 8.
Zakaria R, Pomschar A, Jenkinson MD, Tonn JC, Belka C, Ertl- Wagner B, et al. Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence. J Neurooncol. 2017;131(3):549-54. doi: 10.1007/s11060-016-2320-9.
da Cruz LCH Jr, Gasparetto EL. Diffusion-Weighted MR Imaging in Brain Tumor. MAGNETOM Flash 2/2008. https:// www.siemens-healthineers.com/magnetic-resonance-imaging/magnetom-world.
Weiss SW, Goldblum JR, Folpe AL. Enzinger and Weiss’s soft tissue tumors E-Book. Mosby; 2007.
Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology. 2006;239(3):632- 649. doi:10.1148/radiol.2393042031
Peter ID, Linest MS, Heineman EF. Etiology of brain tumors in adults. Epidemiologic Recievers 1995;17(2):38-414.
Mori S, Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron. 2006;51(5):527-39. doi: 10.1016/j.neuron.2006.08.012.
- Abstract Viewed: 314 times
- PDF Downloaded: 308 times